Novel Morphologic and Genetic Analysis of Cancer Cells in a 3D Microenvironment Identifies STAT3 as a Regulator of

Min Chul Park1, Hyobin Jeong2, Sung Hwa Son3

  • 1Medicinal Bioconvergence Research Center, Seoul National University, Seoul, Korea. Advanced Institutes of Convergence Technology, Seoul National University, Suwon, Korea.

Cancer Research
|December 18, 2015
PubMed

Insights

Researchers identified round multicellular tumor spheroids as having a permeability barrier, linked to JAK-STAT signaling. Inhibiting STAT3 in these spheroids and in mouse models improved anticancer drug delivery and sensitivity, offering new strategies for drug resistance.

Area of Science:

  • Oncology
  • Cancer Biology
  • Drug Delivery

Background:

  • Tumor permeability significantly impacts drug delivery and treatment effectiveness.
  • Lack of systematic methods to identify factors creating tumor microenvironment permeability barriers.
  • Multicellular tumor spheroids (MTS) offer a 3D in vitro model to study tumor behavior.

Purpose of the Study:

  • To identify cellular processes and pathways associated with spheroid structure and permeability barriers.
  • To correlate spheroid morphology with genetic information to understand tumor microenvironment functions.
  • To investigate the role of JAK-STAT signaling in tumor spheroid permeability and drug resistance.

Main Methods:

  • Generated and classified spheroids from 100 cancer cell lines based on morphology.
  • Correlated spheroid morphology with genetic data to identify key cellular processes.
  • Utilized STAT3 inhibition in spheroids and a mouse xenograft model to assess drug sensitivity and tumor growth.

Main Results:

  • Identified four distinct spheroid morphologies, with round, compact spheroids exhibiting hypoxic cores and drug permeability barriers.
  • Revealed JAK-STAT signaling as a key pathway activated in round spheroids.
  • STAT3 inhibition altered spheroid morphology, enhanced drug sensitivity, and reduced tumor growth in vivo.

Conclusions:

  • Integrates 3D culture and genetic profiling to identify factors governing tumor microenvironment permeability barriers.
  • JAK-STAT signaling is a critical factor in spheroid integrity and drug resistance.
  • Targeting STAT3 offers a potential strategy to overcome drug resistance and improve cancer therapy.